E-LIB Suche - Ergebnisse für: Kabashima, Kenji

1

Metabolic reprogramming and macrophage polarization in gran..:

Nakamizo, Satoshi ; Kabashima, Kenji
International Immunology. , 2024

Link: https://doi.org/10.1093/..

2

Safety, efficacy, and pharmacokinetics of delgocitinib oint..:

Nakagawa, Hidemi ; Igarashi, Atsuyuki ; Saeki, Hidehisa...
Allergology International. 73 (2024) 1 - p. 137-142 , 2024

Link: https://doi.org/10.1016/..

3

Correction to: OX40 in the Pathogenesis of Atopic Dermatiti..:

Croft, Michael ; Esfandiari, Ehsanollah ; Chong, Camilla...
American Journal of Clinical Dermatology. 25 (2024) 3 - p. 463-463 , 2024

Link: https://doi.org/10.1007/..

4

TARC/CCL17 reflects the severity of pemphigus (pemphigus vu..:

Takegami, Tomoya ; Yonekura, Satoru ; Nomura, Takashi..
JEADV Clinical Practice. , 2024

Link: https://doi.org/10.1002/..

5

OX40 in the Pathogenesis of Atopic Dermatitis—A New Therape..:

Croft, Michael ; Esfandiari, Ehsanollah ; Chong, Camilla...
American Journal of Clinical Dermatology. 25 (2024) 3 - p. 447-461 , 2024

Link: https://doi.org/10.1007/..

6

Abrocitinib efficacy and safety in moderate-to-severe atopi..:

Alexis, Andrew F. ; Silverberg, Jonathan I. ; Rice, Zakiya P....
Annals of Allergy, Asthma & Immunology. 132 (2024) 3 - p. 383-389.e3 , 2024

Link: https://doi.org/10.1016/..

7

Summary of Research: An Anti-OX40 Antibody to Treat Moderat..:

Guttman-Yassky, Emma ; Simpson, Eric L. ; Reich, Kristian...
Advances in Therapy. 41 (2024) 3 - p. 928-931 , 2024

Link: https://doi.org/10.1007/..

8

Targeting IL‐13 with tralokinumab normalizes type 2 inflamm..:

Guttman‐Yassky, Emma ; Kabashima, Kenji ; Staumont‐Salle, Delphine...
Allergy. , 2024

Link: https://doi.org/10.1111/..

9

TRPV1-positive sensory nerves and neuropeptides are involve..:

Usui, Kenji ; Nakashima, Chisa ; Takahashi, Sonoko...
Journal of Allergy and Clinical Immunology. 153 (2024) 3 - p. 868-873.e4 , 2024

Link: https://doi.org/10.1016/..

10

Presence of immunoglobulin E‐expressing antibody‐secreting ..:

Budair, Fatimah ; Kambe, Naotomo ; Kogame, Toshiaki...
Experimental Dermatology. 33 (2024) 4 - p. , 2024

Link: https://doi.org/10.1111/..

11

Proteasome inhibitor‐associated histiocytoid Sweet's syndro..:

Cho, Ryang ; Nakajima, Saeko ; Kaku, Yo...
The Journal of Dermatology. , 2024

Link: https://doi.org/10.1111/..

12

Necessary and sufficient factors of keratinocytes in psoria..:

Dainichi, Teruki ; Matsumoto, Reiko ; Sakurai, Kenji.
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

13

Exome sequencing reveals biallelic inactivation of KMT2C in..:

Hirano-Lotman, Yui ; Ishida, Yoshihiro ; Kaku, Yo..
JAAD Case Reports. , 2024

Link: https://doi.org/10.1016/..

14

Comparative analysis of CAII and GCDFP‐15 expression in swe..:

Sakiyama, Tomoki ; Nakamizo, Satoshi ; Kabashima, Kenji
The Journal of Dermatology. , 2024

Link: https://doi.org/10.1111/..

15

Enhancement of Skin Barrier Function and Augmentation of Ep..:

Nakamizo, Satoshi ; Yan, Xianghong ; Kabashima, Kenji
Journal of Dermatological Science. , 2024

Link: https://doi.org/10.1016/..